Cargando…
All-Cause and Specific-Cause Mortality Risk After Roux-en-Y Gastric Bypass in Patients With and Without Diabetes
OBJECTIVE: This study assessed all-cause and specific-cause mortality after Roux-en-Y gastric bypass (RYGB) and in matched control subjects, stratified by diabetes status. RESEARCH DESIGN AND METHODS: RYGB patients were matched by age, BMI, sex, and diabetes status at time of surgery to nonsurgical...
Autores principales: | , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Diabetes Association
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5606311/ https://www.ncbi.nlm.nih.gov/pubmed/28760742 http://dx.doi.org/10.2337/dc17-0519 |
_version_ | 1783265126404587520 |
---|---|
author | Lent, Michelle R. Benotti, Peter N. Mirshahi, Tooraj Gerhard, Glenn S. Strodel, William E. Petrick, Anthony T. Gabrielsen, Jon D. Rolston, David D. Still, Christopher D. Hirsch, Annemarie G. Zubair, Fahad Cook, Adam Carey, David J. Wood, G. Craig |
author_facet | Lent, Michelle R. Benotti, Peter N. Mirshahi, Tooraj Gerhard, Glenn S. Strodel, William E. Petrick, Anthony T. Gabrielsen, Jon D. Rolston, David D. Still, Christopher D. Hirsch, Annemarie G. Zubair, Fahad Cook, Adam Carey, David J. Wood, G. Craig |
author_sort | Lent, Michelle R. |
collection | PubMed |
description | OBJECTIVE: This study assessed all-cause and specific-cause mortality after Roux-en-Y gastric bypass (RYGB) and in matched control subjects, stratified by diabetes status. RESEARCH DESIGN AND METHODS: RYGB patients were matched by age, BMI, sex, and diabetes status at time of surgery to nonsurgical control subjects using data from the electronic health record. Kaplan-Meier curves and Cox regression were used to assess differences in all-cause and specific-cause mortality between RYGB patients and control subjects with and without diabetes. RESULTS: Of the 3,242 eligible RYGB patients enrolled from January 2004 to December 2015, control subjects were identified for 2,428 (n = 625 with diabetes and n = 1,803 without diabetes). Median postoperative follow-up was 5.8 years for patients with diabetes and 6.7 years for patients without diabetes. All-cause mortality was reduced in RYGB patients compared with control subjects only for those with diabetes at the time of surgery (adjusted hazard ratio 0.44; P < 0.0001). Mortality was not significantly improved in RYGB patients without diabetes compared with control subjects without diabetes (adjusted hazard ratio 0.84; P = 0.37). Deaths from cardiovascular diseases (P = 0.011), respiratory conditions (P = 0.017), and diabetes P = 0.011) were more frequent in control subjects with diabetes than in RYGB patients with diabetes. RYGB patients without diabetes were less likely to die of cancer (P = 0.0038) and respiratory diseases (P = 0.046) than control subjects without diabetes but were at higher risk of death from external causes (P = 0.012), including intentional self-harm (P = 0.025), than control subjects without diabetes. CONCLUSIONS: All-cause mortality benefits of RYGB are driven predominantly by patients with diabetes at the time of surgery. RYGB patients with diabetes were less likely to die of cardiovascular diseases, diabetes, and respiratory conditions than their counterparts without RYGB. |
format | Online Article Text |
id | pubmed-5606311 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | American Diabetes Association |
record_format | MEDLINE/PubMed |
spelling | pubmed-56063112018-10-01 All-Cause and Specific-Cause Mortality Risk After Roux-en-Y Gastric Bypass in Patients With and Without Diabetes Lent, Michelle R. Benotti, Peter N. Mirshahi, Tooraj Gerhard, Glenn S. Strodel, William E. Petrick, Anthony T. Gabrielsen, Jon D. Rolston, David D. Still, Christopher D. Hirsch, Annemarie G. Zubair, Fahad Cook, Adam Carey, David J. Wood, G. Craig Diabetes Care Cardiovascular and Metabolic Risk OBJECTIVE: This study assessed all-cause and specific-cause mortality after Roux-en-Y gastric bypass (RYGB) and in matched control subjects, stratified by diabetes status. RESEARCH DESIGN AND METHODS: RYGB patients were matched by age, BMI, sex, and diabetes status at time of surgery to nonsurgical control subjects using data from the electronic health record. Kaplan-Meier curves and Cox regression were used to assess differences in all-cause and specific-cause mortality between RYGB patients and control subjects with and without diabetes. RESULTS: Of the 3,242 eligible RYGB patients enrolled from January 2004 to December 2015, control subjects were identified for 2,428 (n = 625 with diabetes and n = 1,803 without diabetes). Median postoperative follow-up was 5.8 years for patients with diabetes and 6.7 years for patients without diabetes. All-cause mortality was reduced in RYGB patients compared with control subjects only for those with diabetes at the time of surgery (adjusted hazard ratio 0.44; P < 0.0001). Mortality was not significantly improved in RYGB patients without diabetes compared with control subjects without diabetes (adjusted hazard ratio 0.84; P = 0.37). Deaths from cardiovascular diseases (P = 0.011), respiratory conditions (P = 0.017), and diabetes P = 0.011) were more frequent in control subjects with diabetes than in RYGB patients with diabetes. RYGB patients without diabetes were less likely to die of cancer (P = 0.0038) and respiratory diseases (P = 0.046) than control subjects without diabetes but were at higher risk of death from external causes (P = 0.012), including intentional self-harm (P = 0.025), than control subjects without diabetes. CONCLUSIONS: All-cause mortality benefits of RYGB are driven predominantly by patients with diabetes at the time of surgery. RYGB patients with diabetes were less likely to die of cardiovascular diseases, diabetes, and respiratory conditions than their counterparts without RYGB. American Diabetes Association 2017-10 2017-07-31 /pmc/articles/PMC5606311/ /pubmed/28760742 http://dx.doi.org/10.2337/dc17-0519 Text en © 2017 by the American Diabetes Association. http://www.diabetesjournals.org/content/licenseReaders may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered. More information is available at http://www.diabetesjournals.org/content/license. |
spellingShingle | Cardiovascular and Metabolic Risk Lent, Michelle R. Benotti, Peter N. Mirshahi, Tooraj Gerhard, Glenn S. Strodel, William E. Petrick, Anthony T. Gabrielsen, Jon D. Rolston, David D. Still, Christopher D. Hirsch, Annemarie G. Zubair, Fahad Cook, Adam Carey, David J. Wood, G. Craig All-Cause and Specific-Cause Mortality Risk After Roux-en-Y Gastric Bypass in Patients With and Without Diabetes |
title | All-Cause and Specific-Cause Mortality Risk After Roux-en-Y Gastric Bypass in Patients With and Without Diabetes |
title_full | All-Cause and Specific-Cause Mortality Risk After Roux-en-Y Gastric Bypass in Patients With and Without Diabetes |
title_fullStr | All-Cause and Specific-Cause Mortality Risk After Roux-en-Y Gastric Bypass in Patients With and Without Diabetes |
title_full_unstemmed | All-Cause and Specific-Cause Mortality Risk After Roux-en-Y Gastric Bypass in Patients With and Without Diabetes |
title_short | All-Cause and Specific-Cause Mortality Risk After Roux-en-Y Gastric Bypass in Patients With and Without Diabetes |
title_sort | all-cause and specific-cause mortality risk after roux-en-y gastric bypass in patients with and without diabetes |
topic | Cardiovascular and Metabolic Risk |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5606311/ https://www.ncbi.nlm.nih.gov/pubmed/28760742 http://dx.doi.org/10.2337/dc17-0519 |
work_keys_str_mv | AT lentmicheller allcauseandspecificcausemortalityriskafterrouxenygastricbypassinpatientswithandwithoutdiabetes AT benottipetern allcauseandspecificcausemortalityriskafterrouxenygastricbypassinpatientswithandwithoutdiabetes AT mirshahitooraj allcauseandspecificcausemortalityriskafterrouxenygastricbypassinpatientswithandwithoutdiabetes AT gerhardglenns allcauseandspecificcausemortalityriskafterrouxenygastricbypassinpatientswithandwithoutdiabetes AT strodelwilliame allcauseandspecificcausemortalityriskafterrouxenygastricbypassinpatientswithandwithoutdiabetes AT petrickanthonyt allcauseandspecificcausemortalityriskafterrouxenygastricbypassinpatientswithandwithoutdiabetes AT gabrielsenjond allcauseandspecificcausemortalityriskafterrouxenygastricbypassinpatientswithandwithoutdiabetes AT rolstondavidd allcauseandspecificcausemortalityriskafterrouxenygastricbypassinpatientswithandwithoutdiabetes AT stillchristopherd allcauseandspecificcausemortalityriskafterrouxenygastricbypassinpatientswithandwithoutdiabetes AT hirschannemarieg allcauseandspecificcausemortalityriskafterrouxenygastricbypassinpatientswithandwithoutdiabetes AT zubairfahad allcauseandspecificcausemortalityriskafterrouxenygastricbypassinpatientswithandwithoutdiabetes AT cookadam allcauseandspecificcausemortalityriskafterrouxenygastricbypassinpatientswithandwithoutdiabetes AT careydavidj allcauseandspecificcausemortalityriskafterrouxenygastricbypassinpatientswithandwithoutdiabetes AT woodgcraig allcauseandspecificcausemortalityriskafterrouxenygastricbypassinpatientswithandwithoutdiabetes |